Updates matching "Access to Health Care"

The Wyoming Senate is set to consider House Bill 162 to increase access to Medicaid for an estimated 25,000 low-income, uninsured Wyoming residents. The bill passed the House last week, and the American Cancer Society Cancer Action Network (ACS CAN), advocacy affiliate of the American Cancer Society, and the Association for Clinical Oncology (ASCO), urge the Senate to follow suit and pass this lifesaving legislation.

The New Jersey Assembly has passed a bill to control the practice of Step Therapy (fail first therapy.) Government Relations Diretor Michael Davoli commented. m

Cheyenne, Wyo.—Today, the Wyoming House of Representatives passed legislation that paves the way to increase access to Medicaid for thousands of low-income, uninsured Wyoming residents. The Senate will now consider House Bill 162. Following is a statement from R.J. Ours, the government relations director for the American Cancer Society Cancer

The House Energy and Commerce Committee will hold a hearing today—the eleventh anniversary of the signing of the Affordable Care Act (ACA) into law—on several bills aimed at strengthening the ACA. The bills include funding for outreach and enrollment efforts, money for more navigators to help people find and select coverage, limiting access to short-term limited duration health plans, and bills to reduce premiums and encourage Medicaid expansion, among others.

CHEYENNE—Tonight the House Revenue Committee passed House Bill 162 that could increase access to Medicaid for thousands of low-income, uninsured Wyoming residents. Following is a statement from R.J. Ours, the government relations director for the American Cancer Society Cancer Action Network: "Today’s vote is a key step forward for thousands

A bill re-introduced in the U.S. House of Representatives late Tuesday aims to improve access to new and innovative cancer screenings among Medicare beneficiaries in order to increase early detection of more cancers for more Americans.

The Centers for Medicare and Medicaid Services (CMS) announced this week that it will not proceed with additional flexibilities to a Part D Payment Modernization Model that would have allowed participating Medicare Part D plans to limit coverage of drugs within the “six protected drug classes.”